Catenarin

Catenarin

SCHEMBL29359362

Cc1cc(O)c2c(c1O)C(=O)c1cc(O)cc(O)c1C2=O

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.72
▸ MAPT P10636 4/20 0.72
▸ KMT2A Q03164 4/20 0.72
▸ KDM4E B2RXH2 2/20 0.72
▸ USP2 O75604 1/20 0.72
▸ ELANE P08246 2/20 0.67
▸ ALDH1A1 P00352 3/20 0.62
▸ HPGD P15428 2/20 0.62
▸ RECQL P46063 2/20 0.62
▸ POLB P06746 2/20 0.62
▸ CYP3A4 P08684 2/20 0.62
▸ APEX1 P27695 2/20 0.62
▸ MAPK1 P28482 2/20 0.62
▸ TDP1 Q9NUW8 2/20 0.62
▸ PIM1 P11309 2/20 0.62
▸ ESR1 P03372 2/20 0.62
▸ ESR2 Q92731 2/20 0.62
▸ NPC1 O15118 1/20 0.62
▸ PTP4A3 O75365 1/20 0.62
▸ GMNN O75496 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Catenarin SCHEMBL9175437 1.00 MEN1 (0.72) MEN1MAPTKMT2AKDM4EUSP2
SCHEMBL6841060 0.88 ELANE (0.60) MEN1MAPTKMT2AKDM4EUSP2
SCHEMBL13570040 0.86 MAPT (0.72) MEN1MAPTKMT2AKDM4EUSP2
1,4,5,8-Tetrahydroxy-2,6-Dimethylanthroquinone SCHEMBL30384695 0.85 MEN1 (1.00) MEN1MAPTKMT2AKDM4EUSP2
SCHEMBL29359531 0.85 MAPT (0.60) MEN1MAPTKMT2AKDM4EUSP2
SCHEMBL29359667 0.85 MAPT (0.60) MEN1MAPTKMT2AKDM4EUSP2
SCHEMBL16226946 0.85 MAPT (0.60) MEN1MAPTKMT2AKDM4EUSP2
Parietin SCHEMBL16226462 0.84 MAPT (0.66) MEN1MAPTKMT2AKDM4EUSP2
Parietin SCHEMBL29356669 0.84 MAPT (0.66) MEN1MAPTKMT2AKDM4EUSP2
SCHEMBL2771631 0.81 BCL2 (0.76) MEN1MAPTKMT2AELANEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120136690-A Separation and purification method of emodin and chain vermicular spore metabolized by Fuzhuan tea aspergillus coronatus and application of emodin and chain vermicular spore as antibacterial agent 南京农业大学 2025-06-13 — — CN claimed
EP-3943085-A2 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION ETH Zurich (CH) 2022-01-26 — — EP claimed
CN-121294567-A Use of Xie Wa aspergillus BYST01 secondary metabolite in promoting lettuce growth 安徽农业大学 2026-01-09 — — CN disclosed
US-20250360073-A1 SOLUBILIZING PIGMENTS EXTRACTED FROM FUNGI FOR APPLICATIONS SUCH AS COSMETIC PRODUCTS ADLER JESSE (US) 2025-11-27 — — US disclosed
CN-120136690-A Separation and purification method of emodin and chain vermicular spore metabolized by Fuzhuan tea aspergillus coronatus and application of emodin and chain vermicular spore as antibacterial agent 南京农业大学 2025-06-13 — — CN disclosed
CN-120136690-A Separation and purification method of emodin and chain vermicular spore metabolized by Fuzhuan tea aspergillus coronatus and application of emodin and chain vermicular spore as antibacterial agent 南京农业大学 2025-06-13 — — CN disclosed
CN-119950445-A Lipuidambaris triterpene compound microcapsule and preparation method and application thereof 安徽农业大学 2025-05-09 — — CN disclosed
WO-2025059358-A1 FUNGAL STRAINS HAVING REDUCED OR ELIMINATED MYCOTOXIN, ETHANOL, AND/OR PIGMENT PRODUCTION CAPACITY THE FYNDER GROUP, INC. (US) 2025-03-20 — — WO disclosed
CN-117462580-A Application of cynara scolymus polyphenol 浙江省农业科学院 2024-01-30 — — CN disclosed
CN-115539510-A Plane air bearing 上海船鸿科技有限公司 2022-12-30 — — CN disclosed
CN-114944575-A Electrical connector, electrical system comprising such a connector and rail vehicle comprising such a system 阿尔斯通控股公司 2022-08-26 — — CN disclosed
CN-114065466-A Virtualized cable modeling for manufacturing resource simulation 达索系统美国公司 2022-02-18 — — CN disclosed
EP-3943085-A2 TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION ETH Zurich (CH) 2022-01-26 — — EP disclosed
Send feedback